Will Moller is a Clinical Genomics Director heading up validation and various professional services PierianDx offers to clients.
Prior to PierianDx, Moller acted as Entrepreneur-in-residence at Nidus Partners, wherein he identified and evaluated promising new technologies in their infancy and assisted in building start-up companies surrounding the research. He has his Masters in Biology from Stanford University where he worked in a population genetics laboratory working closely with Sanger sequencing.
Moller brings a wealth of experience validating NGS assays and acting as the scientific leadership with customers during the implementation process ensuring a seamless integration of the native client programs to the PierianDx Clinical Genomics Workspace (CGW). He has personally validated more than fifteen assays, worked on twenty-seven successful customer assay deployments, and personally lead teams working through the implementation of 18 new PierianDx clients.
Every customer is unique in their indicators for success. We work with customers closely to understand these indicators and strive to deliver interactions, support, and knowledge that achieve this success."